Jordi Faus, Autor en Faus & Moliner Abogados

New Spanish rules on commercialization, supply and control of medicinal products for human use

Royal Decree 717/2019 modifying Royal Decree 1345/2007 regulating the authorization procedure, and dispensation conditions for medicinal products for human use

Verónica Carías, Jordi Faus

20 Dec 2019

The Pharma Legal Handbook: Spain

Faus & Moliner has participated in the publication of the first edition of the Spanish chapter of the The Pharma Legal Handbook guide, edited by PharmaBoardroom

Verónica Carías, Lluís Alcover, Laura Marquès, Eduard Rodellar and Juan Martínez

1 Aug 2019

The Pharma Legal Handbook

Which means are appropriate to send an out-of-court complaint: certified mail, certified fax or some other?

Judgement of the Supreme Court, Civil Chamber, of 5 February 2019

Verónica Carías

27 Mar 2019

Capsulas Nº 200

Faus & Moliner participates in the “Chambers Global Practices Guides – Pharmaceutical Advertising 2019”

Jordi Faus, Juan Suárez and Verónica Carías write the chapter about Law and Practice in Spain

Verónica Carías, Juan Suárez and Jordi Faus

28 Feb 2019

CHAMBERS GLOBAL PRACTICES GUIDE

Update of the Spanish rules in connection with the so-called ‘prescription by nurses’ of medicines and medical devices

Royal Decree 1302/2018, amending Royal Decree 954/2015 on the indication, use and dispensation authorization of medicinal products and medical devices by nurses

Verónica Carías

30 Nov 2018

Capsulas Nº196

Nuevas normas sobre indicación, uso y autorización de dispensación enfermera

Verónica Carías

5 Nov 2018

El Global

The public audience and information period for the draft of Royal Decree on the funding and pricing of medical devices is open

Draft of Royal Decree regulating the public funding of medical devices for non-hospitalized patients and setting the commercialization margins

Verónica Carías, Mercè Maresma

10 Aug 2018

Capsulas Nº 193

Transparency wins: third parties can access the documents of a marketing authorization application file

Judgements of the General Court of the European Union, of 5 February 2018, in the Cases T-235/15, T-718/15 and T‑729/15

Verónica Carías

12 Mar 2018

CAPSULAS Nº 188

Siempre es mejor un mal acuerdo que un buen pleito

Verónica Carías

18 Sep 2017

EL GLOBAL

The “global marketing authorisation” covers all subsequent developments of the medicinal product

Judgement of the Court of Justice of the European Union of 28 June 2017, Joined Cases C-629/15 P and C-630/15 P, Novartis vs European Commission

Verónica Carías

27 Jul 2017

New Spanish rules on commercialization, supply and control of medicinal products for human use

Royal Decree 717/2019 modifying Royal Decree 1345/2007 regulating the authorization procedure, and dispensation conditions for medicinal products for human use

The Pharma Legal Handbook: Spain

Faus & Moliner has participated in the publication of the first edition of the Spanish chapter of the The Pharma Legal Handbook guide, edited by PharmaBoardroom

The Pharma Legal Handbook

Which means are appropriate to send an out-of-court complaint: certified mail, certified fax or some other?

Judgement of the Supreme Court, Civil Chamber, of 5 February 2019

Capsulas Nº 200

Faus & Moliner participates in the “Chambers Global Practices Guides – Pharmaceutical Advertising 2019”

Jordi Faus, Juan Suárez and Verónica Carías write the chapter about Law and Practice in Spain

CHAMBERS GLOBAL PRACTICES GUIDE

Update of the Spanish rules in connection with the so-called ‘prescription by nurses’ of medicines and medical devices

Royal Decree 1302/2018, amending Royal Decree 954/2015 on the indication, use and dispensation authorization of medicinal products and medical devices by nurses

Capsulas Nº196

Nuevas normas sobre indicación, uso y autorización de dispensación enfermera

El Global

The public audience and information period for the draft of Royal Decree on the funding and pricing of medical devices is open

Draft of Royal Decree regulating the public funding of medical devices for non-hospitalized patients and setting the commercialization margins

Capsulas Nº 193

Transparency wins: third parties can access the documents of a marketing authorization application file

Judgements of the General Court of the European Union, of 5 February 2018, in the Cases T-235/15, T-718/15 and T‑729/15

CAPSULAS Nº 188

Siempre es mejor un mal acuerdo que un buen pleito

EL GLOBAL

The “global marketing authorisation” covers all subsequent developments of the medicinal product

Judgement of the Court of Justice of the European Union of 28 June 2017, Joined Cases C-629/15 P and C-630/15 P, Novartis vs European Commission

CAPSULAS Nº 184

Uso de cookies